Clinical Trial Update: A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 safety study of the IMOVAX Polio Vaccine in selected cities in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• IMOVAX Polio Vaccine (Inactivated poliovirus vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Polio, Poliomyelitis | Phase 4 | Status: COMPLETED